持续性不卧床腹膜透析腹膜炎治疗新方案

A NEW TREATMENT PROGRAM FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS RELATED PERITONTIS

为了比较两种不同治疗方案对持续性不卧床腹膜透析（ＣＡＰＤ）腹膜炎的疗效，我们研究４１例ＣＡＰＤ腹膜炎，其中２０例（Ａ组）用新方案治疗，２１例（Ｂ组）用以往常规方案治疗。两组的疗效明显不同，表现为Ａ组治愈率较Ｂ组高（９４．０％比７８．６％，Ｐ＜０．０５）；腹膜炎持续时间较Ｂ组短（２．８±１．６天比４．０±２．０天，Ｐ＜０．０５）；腹膜炎复发率较Ｂ组低（１５９±９８．８天比９８±９９．６天，Ｐ＜０．０５）；治疗失败率较Ｂ组低（６．０％比２１．４％，Ｐ＜０．０５）。研究证明：新方案治疗ＣＡＰＤ腹膜炎疗效优于以往的常规治疗方案。

Forty-one cases of peritonitis caused by continuous ambulatory peritoneal dialysis(CAPD) were studied in order to contrast the efficacies of two sorts treatment programs.Twenty cases of them were treated with new program(group A) and twenty-one with conventional program(group B).The treatment efficacy,however,was different.In group A the rate of cure was higher (94.0%vs 78.6%, P<0.05)and the continuance of peritonitis was shorter (2. 8±1.6 days vs 4.0±2.0days,P<0.05) than those in group B.The recurrence rate (159±98.8 days vs 98± 99. 6 days,P <0. 05)and the failure rate of treatment (6.0% vs 21.4%,P<0.05) in group A were both lower than those in group B.The study demonstrtes that the efficacy of the new program is superior to that of conventional program.Renal Research Institute,Sun Yat-Sen University of Medical Sciences,Guangzhou,510080)